Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 1

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(2)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07406828Phase 1Not Yet Recruiting

Psilocybin After Trauma Surgery for Pain

Role: collaborator

NCT06426602Not ApplicableEnrolling By Invitation

mindBEAGLE: Unlocking Functional Communication for Patients With Disorders of Consciousness

Role: collaborator

NCT07222436Recruiting

Circulating Tumor DNA in High Risk Localized Prostate Cancer

Role: collaborator

NCT05597722Phase 4Terminated

Addressing Cognitive Fog in Long-COVID-19 Patients

Role: collaborator

NCT05034718Not ApplicableCompleted

Implementation of the Pittsburgh Infant Brain Injury Score

Role: collaborator

All 5 trials loaded